TFS Capital’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-78,134
| Closed | -$531K | – | 500 |
|
|
2017
Q2 | $531K | Buy |
+78,134
| New | +$531K | 0.21% | 163 |
|
|
2017
Q1 | – | Sell |
-174,408
| Closed | -$1.51M | – | 939 |
|
|
2016
Q4 | $1.51M | Buy |
+174,408
| New | +$1.51M | 0.4% | 42 |
|
|
2016
Q3 | – | Sell |
-60,575
| Closed | -$256K | – | 1096 |
|
|
2016
Q2 | $256K | Sell |
60,575
-75,228
| -55% | -$318K | 0.05% | 658 |
|
|
2016
Q1 | $592K | Sell |
135,803
-262,480
| -66% | -$1.14M | 0.09% | 399 |
|
|
2015
Q4 | $2.44M | Buy |
398,283
+334,774
| +527% | +$2.05M | 0.26% | 123 |
|
|
2015
Q3 | $363K | Sell |
63,509
-239,232
| -79% | -$1.37M | 0.04% | 623 |
|
|
2015
Q2 | $2.26M | Sell |
302,741
-387,018
| -56% | -$2.89M | 0.22% | 126 |
|
|
2015
Q1 | $4.13M | Buy |
689,759
+226,019
| +49% | +$1.35M | 0.4% | 43 |
|
|
2014
Q4 | $3.51M | Buy |
463,740
+438,538
| +1,740% | +$3.32M | 0.33% | 61 |
|
|
2014
Q3 | $131K | Sell |
25,202
-63,781
| -72% | -$332K | 0.01% | 943 |
|
|
2014
Q2 | $384K | Sell |
88,983
-60,202
| -40% | -$260K | 0.03% | 742 |
|
|
2014
Q1 | $610K | Sell |
149,185
-5,549
| -4% | -$22.7K | 0.04% | 655 |
|
|
2013
Q4 | $825K | Sell |
154,734
-39,167
| -20% | -$209K | 0.04% | 637 |
|
|
2013
Q3 | $973K | Buy |
193,901
+85,836
| +79% | +$431K | 0.04% | 591 |
|
|
2013
Q2 | $482K | Buy |
+108,065
| New | +$482K | 0.02% | 914 |
|